Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
The diagnosis of a rare cancer, like alveolar soft part sarcoma, is especially distressing for parents. Not only does this soft tissue tumor require your child to get intensive treatment, it may also be difficult to find accurate information on it. The experts at the Dana-Farber/Children's Hospital Cancer Center are here to help.
An important first step in understanding what lies ahead is familiarizing yourself with the basics about alveolar soft part sarcoma (ASPS):
The detailed information on the following pages will help you gain a better understanding of ASPS and a clearer picture of what to expect.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches alveolar soft part sarcoma
Here at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, we offer the ideal setting, utilizing world-recognized cancer expertise at Dana-Farber and internationally renowned pediatric expertise at Children’s Hospital Boston within the research and educational setting of Harvard Medical School. We are a top cancer center and top children’s hospital.
Children with ASPS are treated through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Bone and Soft Tissue Tumor Program. Kids who need surgery are also treated through Children’s Orthopedic Center.
Our multidisciplinary approach to care ensures in-depth discussion of each case and personalized treatment plans for every child. We integrate expertise from the following specialists:
At Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, we’re conducting research studies that will help clinicians better understand and treat children with soft tissue sarcomas.
Alveolar soft part sarcoma: Reviewed by Megan Anderson, MD, orthopedic surgeon
© Boston Children’s Hospital , 2011
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”